Literature DB >> 21275327

Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer.

Gail M Wilkes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21275327

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  1 in total

Review 1.  Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer.

Authors:  Channing J Paller; Emmanuel S Antonarakis
Journal:  Drug Des Devel Ther       Date:  2011-03-10       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.